NT-proBNP as a Diagnostic Marker in CCF

Dr. Vedavathi R.

Authors

Dr. Vedavathi R.

Keywords:

Abstract

Abstract not found

Downloads

How to Cite

NT-proBNP as a Diagnostic Marker in CCF. (2017). Global Journal of Medical Research, 16(B4), 51-56. https://medicalresearchjournal.org/index.php/GJMR/article/view/1190

Download Citation

References

D Schocken, E Benjamin, G Fonarrow (2008) Prevention of heart failure: A scientific statement from the American heart association councils on Epidemiology and prevention, Clinical Cardiology, Cardiovascular Nursing, and high blood pressure Research; Quality care and Outcomes Research Interdisciplinary Working group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. 117, 2544.

D Mann, L Chakinala, M Heart Failure : Pathophysiology and diagnosis.

D Longo, A Fauci, D Kasper, S Hauser, J Jameson, J Loscalzo Unknown Title. 2, 2112.

Clyde Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald Casey, Mark Drazner, Gregg Fonarow, Stephen Geraci, Tamara Horwich, James Januzzi, Maryl Johnson, Edward Kasper, Wayne Levy, Frederick Masoudi, Patrick Mcbride, John Mcmurray, Judith Mitchell, Pamela Peterson, Barbara Riegel, Flora Sam, Lynne Stevenson, W Tang, Emily Tsai, Bruce Wilkoff (2013) 2013 ACCF/AHA Guideline for the Management of Heart Failure. 128(16), 240-327.

Jjv Mcmurray, S Adamopoulos, S Anker, A Auricchio, M Bohm, K Dickstein (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. 14, 803-869.

Hisham Dokainish (2007) Combining tissue Doppler echocardiography and B-type natriuretic peptide in the evaluation of left ventricular filling pressures: Review of the literature and clinical recommendations. 23(12), 983-989.